Impact from the Recent Issuance of ANVISA Resolution RDC-53/2015 on Pharmaceutical Small Molecule Forced Degradation Study Requirements
By Peter Tattersall, Suwimon Asawasiripong, Ivone Takenaka, and John A. Castoro
American Pharmaceutical Review, March 31, 2016
Wednesday, 20 April 2016
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment